Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease - Wikidata - wikimedia - TriplyDB

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

http://www.wikidata.org/entity/Q33780172

about

Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?Application of metagenomics in the human gut microbiome Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective Toll-like receptors in pathophysiology of liver diseases How Inflammation Impinges on NAFLD: A Role for Kupffer Cells Gut Microbiota and Host Reaction in Liver Diseases Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do Spirulina Protects against Hepatic Inflammation in Aging: An Effect Related to the Modulation of the Gut Microbiota?Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease.Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long-chain n-3 PUFA.Adipocytes as a Link Between Gut Microbiota-Derived Flagellin and Hepatocyte Fat Accumulation.A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.Phenylketonuria and Gut Microbiota: A Controlled Study Based on Next-Generation Sequencing.Hypolactasia is associated with insulin resistance in nonalcoholic steatohepatitis.Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation.Biliary tract external drainage protects against intestinal barrier injury in hemorrhagic shock rats.Perilla Oil Has Similar Protective Effects of Fish Oil on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Gut Dysbiosis.The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease.Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice.Non-alcoholic fatty liver and the gut microbiota.Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression.Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes.The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target?Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice.Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.Nonalcoholic fatty liver disease: Evolving paradigms.Immunoglobulin A and liver diseases.Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.Aerobic but not Resistance Exercise Can Induce Inflammatory Pathways via Toll-Like 2 and 4: a Systematic Review.Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials.Impact of Time-Restricted Feeding and Dawn-to-Sunset Fasting on Circadian Rhythm, Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease.The day will come to treat HCC in a drugstore?Growth Hormone Control of Hepatic Lipid Metabolism.

P2860

Q26796448-8AE3D4F8-6EA0-4F6B-AF2E-539630933EA1 Q26798033-9B177D38-4406-4D69-9EA7-8588332CD1E7 Q26851464-503F9B39-9B83-44E9-8617-89708FB1D357 Q26863476-CAC7A5ED-EA29-4B5F-9FF4-88963E180C7B Q28070077-CA2F3C03-40D4-43BC-A3EE-5C4040F5F186 Q28083001-61C2E66C-EA88-4382-8B2B-2CC4CBE13705 Q28083295-449E3792-6B6D-48B2-A6B0-22B778F5BDFE Q33579420-811E6EFC-E598-41F2-B7A2-136A890CCF98 Q33716191-A10C1BCE-64AC-447F-829B-DC1633E6FFDC Q33852208-B58D13A9-D3F2-4BB2-BF74-59BDA65626EA Q34750494-A86A18CE-30E3-44F3-A654-08D352059BD4 Q35667925-9E2AE47B-4FDF-458B-889C-2D6CFD4BC081 Q35753377-DC39E7BD-C469-42A1-9A68-D56791F239C1 Q35976370-D3ED8052-4620-4F57-A770-F97B344C71EC Q36005098-42F57A78-A0A1-4F83-AAE8-1F9AEAAFFCD4 Q36060094-19F45DBE-895E-474C-8A88-FE8288EFD615 Q36137908-91F19E36-31B9-4087-83E1-B41BA090E4A7 Q36318355-4E4FF95D-570A-4237-819B-B71C8092D14B Q36350217-939DC546-0A02-40E6-AF02-2A16915B12E9 Q36718783-D341C8A8-6C39-4523-AE34-F4B8303E6AFC Q36751990-F8838703-30AD-4E03-8F46-65231907D728 Q36775835-F23459A5-F763-4F52-AE4E-872254ECCAC0 Q36941050-122C8FD8-774C-4410-89A2-1906D72D7BFC Q37215934-41185756-7C95-4C5D-9D26-A1CD28CD84C7 Q37563673-D0D45D2B-0871-4911-8B93-A4DB58BE17E4 Q37624461-70ADE277-90A1-4C8B-9DD4-71C5B7843D6B Q38660769-6558B466-7503-4F72-8D86-0C484D807B02 Q39445103-A2613FB8-4CE3-4F95-A297-789F97154931 Q40202938-24C84306-E1CC-48E9-A946-B11C4A6B6BBB Q41552497-56C94698-8690-4D3D-BD57-7F6ABA982482 Q42367659-B04BC4AF-4E59-41D3-9645-8BCB880E723F Q42695154-07D040C7-7CC5-487F-9093-63745318BA40 Q46387163-0E0B0105-D436-4C52-9772-F4CEBC7849E9 Q46450900-BA23DBF2-E783-40B1-B7CD-1F8FC1A4FA83 Q47116789-B1A20E31-D42A-4AB1-8D04-A2A7FA7874F7 Q47130720-160B8C99-C5D6-4D28-BA25-3EDB6355C552 Q47895675-727D4316-FA5D-498A-A835-93018B00112A Q48214770-CED51EAD-9C15-4AED-A0BF-3D46A0F5DC25 Q49174925-C145F5B5-E105-44C4-B30F-A5D2B755606F Q49329608-A83CC799-6C1E-4E2C-A823-1F49E4B6A2CF

P2860

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

http://www.wikidata.org/entity/Q33780172

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

@ast

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

@en

type

label

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

@ast

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

@en

prefLabel

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

@ast

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

@en

P1433

Q33780172-BD65D6D8-9825-4DDB-8AC6-E3AB8C16FC42

P1476

Q33780172-8FFF4A2F-3809-4C92-BC80-C76037049F66

P2093

Q33780172-85C5138C-48A8-4912-8F93-4C091655BA16

Q33780172-8920FFD1-17ED-4BF5-BF76-89CE8CDF61AE

P2860

Q33780172-02638780-C1A5-4280-B53B-F547DBAA82E6

Q33780172-02691022-70F9-4BDC-B6DC-483BFBF45FB6

Q33780172-02B7F3C5-3DF5-4E93-ACEC-A49B5F338922

Q33780172-03CC1C50-94BF-49AA-AAFF-43E16331DE84

Q33780172-07204945-E4B2-40E1-B799-039C5A62CDDB

Q33780172-07D1A51D-CBEA-4F0F-BA56-532D2A89A5B7

Q33780172-0A6398C8-5B01-4095-9BB5-95499654A818

Q33780172-0CDB18A9-2DDF-4F00-916B-AB11B262AB43

Q33780172-0CF8AD15-07D4-4FD4-B0FE-3D1381E00AB8

Q33780172-0D60A36A-677C-4A2D-A378-AE921FCCB41C

P304

Q33780172-6FF5118B-4BA7-4AF0-BBF7-D51B52CAB8F2

P31

Q33780172-22B91496-8144-4C29-A549-299A3C2ECA5B

P356

Q33780172-F1D01EB3-7CEF-4BB5-BF22-8A29F6177903

P407

Q33780172-C579CF91-CF8C-4CE4-93E6-4146C1363C1A

P433

Q33780172-63F24C55-285B-4B1E-8622-68C676DAC6D8

P478

Q33780172-02CCAB61-72BC-4B46-9F7F-1F30E911C4DF

P577

Q33780172-6018D381-4E82-4B1E-85A6-FAC20E8AA7C2

P698

Q33780172-F845903B-3DFC-4C56-8565-8658C99CF5CF

P921

Q33780172-9D0D5141-8E84-416D-846A-371D15E4EBD2

P932

Q33780172-62AE4F54-4C8E-4318-B3D6-787F7564D5DC

P356

WJG.V20.I23.7381

P1433

World Journal of Gastroenterology

P1476

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

@en

P2093

Hirohide Ohnishi

http://www.w3.org/2001/XMLSchema#string

Kouichi Miura

http://www.w3.org/2001/XMLSchema#string

P2860

Gut Microbiota and Its Possible Relationship With Obesity

A core gut microbiome in obese and lean twins

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

Microbial ecology: human gut microbes associated with obesity

Host-bacterial mutualism in the human intestine

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

The gut microbiota as an environmental factor that regulates fat storage

Autocrine loop between TGF-beta1 and IL-1beta through Smad3- and ERK-dependent pathways in rat pancreatic stellate cells

Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms

Spherical lactic acid bacteria activate plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cells

P304

7381-7391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I23.7381

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24966608

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

4064083

http://www.w3.org/2001/XMLSchema#string